62009-38-5 Usage
Uses
Used in Dye and Pigment Production:
6-Amino-5-nitro-3-pyridinesulfonic acid is used as a key component in the production of dyes and pigments, contributing to the coloration of various materials due to its chemical structure and properties.
Used in Analytical Chemistry:
In the field of analytical chemistry, 6-Amino-5-nitro-3-pyridinesulfonic acid is employed as a reagent for the determination of various metal ions, leveraging its water solubility and reactivity with metal ions to facilitate accurate analysis.
Used in Pharmaceutical Industry:
6-Amino-5-nitro-3-pyridinesulfonic acid is utilized as a building block in the synthesis of various drugs within the pharmaceutical industry, playing a crucial role in the development of new medicinal compounds.
Used in Organic Synthesis:
6-Amino-5-nitro-3-pyridinesulfonic acid also serves as an intermediate in organic synthesis, where it can be further transformed into other useful chemical entities, showcasing its versatility in chemical reactions.
Used in Coordination Chemistry:
6-Amino-5-nitro-3-pyridinesulfonic acid is known for its ability to form coordination compounds with metal ions, which is an important application in coordination chemistry, potentially leading to the development of new materials with specific properties.
Check Digit Verification of cas no
The CAS Registry Mumber 62009-38-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,0,0 and 9 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 62009-38:
(7*6)+(6*2)+(5*0)+(4*0)+(3*9)+(2*3)+(1*8)=95
95 % 10 = 5
So 62009-38-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H5N3O5S/c6-5-4(8(9)10)1-3(2-7-5)14(11,12)13/h1-2H,(H2,6,7)(H,11,12,13)
62009-38-5Relevant academic research and scientific papers
COMPOUNDS AS BCL-2 INHIBITORS
-
Paragraph 251; 276-277, (2021/11/13)
Provided are certain Bcl-2 inhibitors, pharmaceutical compositions thereof, and methods of use thereof.
Solid dispersions containing an apoptosis-inducing agent
-
Page/Page column 278, (2019/03/15)
A pro-apoptotic solid dispersion comprises, in essentially non-crystalline form, a Bcl-2 family protein inhibitory compound of Formula I as defined herein, dispersed in a solid matrix that comprises (a) a pharmaceutically acceptable water-soluble polymeric carrier and (b) a pharmaceutically acceptable surfactant. A process for preparing such a solid dispersion comprises dissolving the compound, the polymeric carrier and the surfactant in a suitable solvent, and removing the solvent to provide a solid matrix comprising the polymeric carrier and the surfactant and having the compound dispersed in essentially non-crystalline form therein. The solid dispersion is suitable for oral administration to a subject in need thereof for treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.
